Recently, we identified 3% and 60% of uterine fibroids harbour specific mutations in MED12 exon 1 and exon 2 respectively of 65 uterine fibroids studied that were collected from Australian women (10). The gene discussed is MED12; the disease is uterine corpus leiomyoma.